Home > Insider Trading > Filing (0001415889-24-004244)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780556	David Jakeman	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713	Vp Of Finance And Accounting	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-02-14	2,660	$1.04	141,232	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit awards granted on January 21, 2020, January 22, 2021, January 18, 2022 and January 17, 2023. The sales of the shares were made pursuant to an automatic sell-to-cover arrangement adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grant of such restricted stock unit awards.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.04 to $1.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.